We found that these mRNAs (IGFBP2/3, YTHDC1/2, METTL3/14/16, YTHDF1/2/3, RBM15) were involved in the m6a-related lncRNA network, and of these, 14 lncRNAs were differentially expressed and associated with the clinical outcome of HCC. Here, METTL3 is linked to hepatocellular carcinoma.